Recombinant MS4A1 (Obinutuzumab Biosimilar) anticorps
Research Grade
Reactivité: Humain
ELISA
Hôte: Mammalian Cells
Monoclonal
unconjugated
Recombinant Antibody
-
- Antigène
- MS4A1 (Obinutuzumab Biosimilar)
- Type d'anticorp
- Recombinant Antibody
- Reactivité
- Humain
-
Hôte
-
Mammalian Cells
- Expression System
- Mammalian cells
-
Clonalité
- Monoclonal
-
Conjugué
- Cet anticorp MS4A1 (Obinutuzumab Biosimilar) est non-conjugé
- Application
- ELISA
- Fonction
- Obinutuzumab Biosimilar - Anti-MS4A1, CD20 mAb
- Attributs du produit
- Antibody Type: IgG1-kappa
- Purification
- Recombinant antibody expressed in mammalien cells and purified.
- Classe de qualité
- Research Grade
- Isotype
- IgG1 kappa
-
-
- Restrictions
- For Research Use only
-
- Buffer
- PBS pH 7.5
- Stock
- -80 °C
- Stockage commentaire
- store at -80°C
-
- Antigène
- MS4A1 (Obinutuzumab Biosimilar)
- Classe de substances
- Biosimilar
- Sujet
-
GA101,RG7159,RO5072759,afutuzumab
Obinutuzumab is a humanized monoclonal antibody that can be used in combination with chlorambucil to treat chronic lymphocytic leukemia. It was sold under the Gazyva brand. There are black box warnings of fatal hepatitis B virus (HBV) reactivation and fatal progressive multifocal leukoencephalopathy (PML). - Numéro CAS
- 949142-50-1
-
Vous êtes ici:
